Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-02 Sale |
2022-03-04 4:12 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Intern'l Operations |
3,052 | $12.01 | $36,655 | 298,367 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-04 4:12 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer |
3,060 | $12.01 | $36,751 | 288,753 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-04 4:11 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Colao Massimilano Chief Commercial Officer |
3,205 | $12.01 | $38,492 | 295,638 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-04 4:11 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
9,068 | $12.01 | $108,907 | 879,395 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-04 4:10 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
4,846 | $12.01 | $58,200 | 288,453 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-04 4:10 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
4,849 | $12.01 | $58,236 | 238,665 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-04 4:17 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director |
40,000 | $22.59 | $903,650 | 13,500 (Direct) |
View |
| 2021-12-13 Purchase |
2021-12-15 4:09 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director |
1,600 | $20.04 | $32,064 | 5,300 (Direct) |
View |
| 2021-11-09 Sale |
2021-11-12 4:18 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
150,000 | $30.25 | $4,537,280 | 83,761 (Direct) |
View |
| 2021-11-09 Sale |
2021-11-12 4:13 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
250,000 | $30.03 | $7,508,300 | 187,299 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 4:24 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
45,000 | $31.64 | $1,423,800 | 267,299 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 4:20 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
45,000 | $31.64 | $1,423,800 | 176,861 (Direct) |
View |
| 2021-10-25 Sale |
2021-10-26 4:33 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
130,000 | $29.75 | $3,867,500 | 69,592 (Direct) |
View |
| 2021-09-21 Sale |
2021-09-22 4:53 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
32,500 | $23.99 | $779,533 | 199,592 (Direct) |
View |
| 2021-09-20 Sale |
2021-09-22 4:31 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
116,000 | $23.44 | $2,718,725 | 241,261 (Direct) |
View |
| 2021-09-15 Sale |
2021-09-16 5:01 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
44,000 | $21.78 | $958,220 | 212,861 (Direct) |
View |
| 2021-09-13 Sale |
2021-09-14 6:16 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
115,000 | $20.89 | $2,402,217 | 426,861 (Direct) |
View |
| 2021-09-10 Sale |
2021-09-14 5:12 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
32,500 | $21.15 | $687,325 | 106,092 (Direct) |
View |
| 2021-09-13 Sale |
2021-09-14 5:11 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
150,000 | $19.84 | $2,976,000 | 139,299 (Direct) |
View |
| 2021-09-07 Sale |
2021-09-08 4:04 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
7,500 | $18.1 | $135,750 | 176,861 (Direct) |
View |
| 2021-09-07 Sale |
2021-09-08 4:03 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
5,000 | $18.3 | $91,500 | 138,592 (Direct) |
View |
| 2021-08-26 Sale |
2021-08-27 4:09 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
22,500 | $17.81 | $400,725 | 184,361 (Direct) |
View |
| 2021-08-25 Sale |
2021-08-26 4:15 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
5,000 | $15.85 | $79,250 | 137,299 (Direct) |
View |
| 2021-08-09 Sale |
2021-08-10 4:11 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
45,000 | $16.03 | $721,350 | 142,299 (Direct) |
View |
| 2021-08-09 Sale |
2021-08-10 4:09 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
5,000 | $16.01 | $80,050 | 206,861 (Direct) |
View |
| 2021-07-28 Sale |
2021-07-29 4:09 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
5,000 | $13.86 | $69,300 | 211,861 (Direct) |
View |
| 2021-06-22 Sale |
2021-06-23 4:06 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
5,000 | $13.76 | $68,800 | 216,861 (Direct) |
View |
| 2021-05-11 Purchase |
2021-05-13 4:17 pm |
Aurinia Pharmaceuticals Inc. | AUPH | MacKay-Dunn R. Hector Director |
4,500 | $11.23 | $50,529 | 6,000 (Direct) |
View |
| 2021-05-11 Purchase |
2021-05-12 4:34 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Intern'l Operations |
9,900 | $10.07 | $99,739 | 9,900 (Direct) |
View |
| 2021-05-11 Purchase |
2021-05-12 4:32 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
5,125 | $10.71 | $54,891 | 13,453 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-02 Option Award |
2022-03-04 4:12 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Intern'l Operations |
290,643 | $0 | 298,367 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 4:12 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer |
290,643 | $0 | 288,753 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 4:11 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Colao Massimilano Chief Commercial Officer |
290,643 | $0 | 295,638 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 4:11 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer |
874,728 | $0 | 879,395 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 4:11 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel |
290,643 | $0 | 293,825 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 4:10 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
206,000 | $0 | 288,453 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 4:10 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
177,786 | $0 | 238,665 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 4:17 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director |
40,000 | $5.08 | 13,500 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 4:17 pm |
N/A 2028-02-08 |
Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director |
40,000 | $0 | 13,500 (Direct) |
View |
| 2021-11-11 Exercise |
2021-11-12 4:18 pm |
N/A 2030-01-28 |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
29,000 | $0 | 83,761 (Direct) |
View |
| 2021-11-11 Exercise |
2021-11-12 4:18 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
29,000 | $18.38 | 83,761 (Direct) |
View |
| 2021-11-10 Exercise |
2021-11-12 4:13 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
130,000 | $5.3 | 187,299 (Direct) |
View |
| 2021-11-10 Exercise |
2021-11-12 4:13 pm |
N/A 2029-01-29 |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
200,000 | $0 | 187,299 (Direct) |
View |
| 2021-11-10 Exercise |
2021-11-12 4:13 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
70,000 | $6.06 | 187,299 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:24 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
45,000 | $5.3 | 267,299 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:24 pm |
N/A 2028-02-01 |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
45,000 | $0 | 267,299 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:20 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
45,000 | $3.2 | 176,861 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:20 pm |
N/A 2027-02-09 |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
45,000 | $0 | 176,861 (Direct) |
View |
| 2021-10-25 Exercise |
2021-10-26 4:33 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
95,000 | $3.2 | 69,592 (Direct) |
View |
| 2021-10-25 Exercise |
2021-10-26 4:33 pm |
N/A 2027-02-09 |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
95,000 | $0 | 69,592 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 4:53 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
11,136 | $3.2 | 199,592 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 4:53 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
16,000 | $2.63 | 199,592 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 4:53 pm |
N/A 2022-12-11 |
Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research |
27,136 | $0 | 199,592 (Direct) |
View |
| 2021-09-20 Exercise |
2021-09-22 4:31 pm |
N/A 2028-02-01 |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
36,000 | $5.3 | 241,261 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 4:31 pm |
N/A 2028-02-01 |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
87,500 | $0 | 241,261 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 4:31 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
70,000 | $6.06 | 241,261 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 4:31 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
10,000 | $18.38 | 241,261 (Direct) |
View |
| 2021-09-14 Exercise |
2021-09-16 5:01 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
44,000 | $5.3 | 212,861 (Direct) |
View |
| 2021-09-14 Exercise |
2021-09-16 5:01 pm |
N/A 2028-02-01 |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
44,000 | $0 | 212,861 (Direct) |
View |
| 2021-09-14 Exercise |
2021-09-14 6:16 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
45,000 | $3.2 | 426,861 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-14 6:16 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
70,000 | $5.3 | 426,861 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-14 6:16 pm |
N/A 2028-02-01 |
Aurinia Pharmaceuticals Inc. | AUPH | Martin Michael Robert Chief Business Officer |
115,000 | $0 | 426,861 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-14 5:11 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
150,000 | $3.2 | 139,299 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-14 5:11 pm |
N/A 2027-02-09 |
Aurinia Pharmaceuticals Inc. | AUPH | Solomons Neil Chief Medical Officer |
150,000 | $0 | 139,299 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-17 4:39 pm |
N/A 2031-06-14 |
Aurinia Pharmaceuticals Inc. | AUPH | Balakrishnan Brinda Director |
53,291 | $0 | 53,291 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 9:23 pm |
N/A 2031-06-14 |
Aurinia Pharmaceuticals Inc. | AUPH | Hagan Joseph P Director |
31,347 | $0 | 31,347 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 9:22 pm |
N/A 2031-06-14 |
Aurinia Pharmaceuticals Inc. | AUPH | Walbert Timothy P Director |
31,347 | $0 | 31,347 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 9:21 pm |
N/A 2031-06-14 |
Aurinia Pharmaceuticals Inc. | AUPH | Billen Daniel Director |
31,347 | $0 | 31,347 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 9:20 pm |
N/A 2031-06-14 |
Aurinia Pharmaceuticals Inc. | AUPH | MILNE GEORGE M JR Director |
31,347 | $0 | 31,347 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 9:19 pm |
N/A 2031-06-14 |
Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director |
31,347 | $0 | 31,347 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 9:17 pm |
N/A 2031-06-14 |
Aurinia Pharmaceuticals Inc. | AUPH | MacKay-Dunn R. Hector Director |
31,347 | $0 | 31,347 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 9:16 pm |
N/A 2031-06-14 |
Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director |
31,347 | $0 | 31,347 (Direct) |
View |